Detalhe da pesquisa
1.
Microbiota triggers STING-type I IFN-dependent monocyte reprogramming of the tumor microenvironment.
Cell
; 184(21): 5338-5356.e21, 2021 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34624222
2.
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade.
Cell
; 170(6): 1120-1133.e17, 2017 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28803728
3.
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
Nature
; 606(7915): 797-803, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705814
4.
Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma.
Immunity
; 44(6): 1444-54, 2016 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27332733
5.
Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
Nature
; 613(7945): E3, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36627494
6.
Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells.
Nature
; 558(7709): 307-312, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29849141
7.
Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies.
Proc Natl Acad Sci U S A
; 116(45): 22699-22709, 2019 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31636208
8.
The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy.
Trends Immunol
; 39(11): 900-920, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30392721
9.
The Rationale and Emerging Use of Neoadjuvant Immune Checkpoint Blockade for Solid Malignancies.
Ann Surg Oncol
; 25(7): 1814-1827, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29500764
10.
Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia.
Blood
; 127(9): 1117-27, 2016 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26813675
11.
Hallmarks of response to immune checkpoint blockade.
Br J Cancer
; 117(1): 1-7, 2017 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28524159
12.
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation.
Nature
; 468(7326): 968-72, 2010 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-21107320
13.
Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration.
J Exp Med
; 220(2)2023 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36367776
14.
Hallmarks of Resistance to Immune-Checkpoint Inhibitors.
Cancer Immunol Res
; 10(4): 372-383, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35362046
15.
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.
Blood
; 114(3): 535-46, 2009 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-19451549
16.
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.
Science
; 374(6575): 1632-1640, 2021 Dec 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34941392
17.
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade.
Nat Med
; 27(8): 1432-1441, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34239137
18.
The human tumor microbiome is composed of tumor type-specific intracellular bacteria.
Science
; 368(6494): 973-980, 2020 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32467386
19.
Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas.
Mol Ther Oncolytics
; 11: 20-38, 2018 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30306125
20.
Gene Targeting Meets Cell-Based Therapy: Raising the Tail, or Merely a Whimper?
Clin Cancer Res
; 23(2): 327-329, 2017 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27836861